Skip to main content
Erschienen in: Inflammation Research 6/2023

15.05.2023 | Original Research Paper

Causal associations of circulating Helicobacter pylori antibodies with stroke and the mediating role of inflammation

verfasst von: Xingzhi Guo, Peng Tang, Xin Zhang, Rui Li

Erschienen in: Inflammation Research | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Observational studies have shown that Helicobacter pylori (H. pylori) infection and H. pylori antibodies are associated with an increased risk of stroke. However, which and how H. pylori antibodies serve as the causal determinant of the development of stroke remains largely unknown.

Methods

Genome-wide association studies (GWAS) on seven different antibodies of H. pylori-specific proteins, stroke, and stroke subtypes were included in this study. Mendelian randomization (MR) and multivariable MR (MVMR) analysis were performed to assess the causal associations between H. pylori antibodies and the development of stroke and to determine the potential mechanisms underlying the associations.

Results

Genetically predicted serum H. pylori vacuolating cytotoxin-A (VacA) antibody level was associated with an increased risk of all-cause stroke (odds ratio [OR] = 1.04, 95% CI 1.01–1.07, P = 0.017) and cardioembolic stroke (CES, OR = 1.11, 95% CI 1.04–1.18, P = 0.001). The results of multivariable MR (MVMR) showed that C-reactive protein (CRP), but not monocyte chemoattractant protein-1 and peptic ulcer, mediated the causal effects of VacA-positive H. pylori infection on all-cause stroke and CES. No strong causal associations were found between other H. pylori antibodies and stroke and its subtypes.

Conclusions

Our results demonstrate that H. pylori VacA antibody is the only causal determinant associated with the risk of stroke in the spectrum of H. pylori-related antibodies, in which CRP may mediate the association. This study suggests that inhibition of the CRP signaling pathway may reduce the risk of stroke in patients with VacA-positive H. pylori infection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17:18–29.PubMedCrossRef Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17:18–29.PubMedCrossRef
2.
Zurück zum Zitat Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1151–210.CrossRef Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1151–210.CrossRef
3.
Zurück zum Zitat Kumar KP, Wong CH. Imbalance in the force: the dark side of the microbiota on stroke risk and progression. Curr Opin Neurobiol. 2020;62:10–6.CrossRef Kumar KP, Wong CH. Imbalance in the force: the dark side of the microbiota on stroke risk and progression. Curr Opin Neurobiol. 2020;62:10–6.CrossRef
4.
Zurück zum Zitat Shindler-Itskovitch T, Chodick G, Shalev V, Muhsen K. Helicobacter pylori infection and prevalence of stroke. Helicobacter. 2019;24: e12553.PubMedCrossRef Shindler-Itskovitch T, Chodick G, Shalev V, Muhsen K. Helicobacter pylori infection and prevalence of stroke. Helicobacter. 2019;24: e12553.PubMedCrossRef
5.
Zurück zum Zitat Mezmale L, Coelho LG, Bordin D, Leja M. Review: epidemiology of Helicobacter pylori. Helicobacter. 2020;25(Suppl 1): e12734.PubMed Mezmale L, Coelho LG, Bordin D, Leja M. Review: epidemiology of Helicobacter pylori. Helicobacter. 2020;25(Suppl 1): e12734.PubMed
6.
Zurück zum Zitat Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.PubMedCrossRef Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.PubMedCrossRef
7.
Zurück zum Zitat Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6:185–94.PubMedCrossRef Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6:185–94.PubMedCrossRef
8.
Zurück zum Zitat Butler-Laporte G, Kreuzer D, Nakanishi T, Harroud A, Forgetta V, Richards JB. Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study. In Open forum infectious diseases. 2020; Oxford University Press US. ofaa450. Butler-Laporte G, Kreuzer D, Nakanishi T, Harroud A, Forgetta V, Richards JB. Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study. In Open forum infectious diseases. 2020; Oxford University Press US. ofaa450.
9.
Zurück zum Zitat Nejati S, Karkhah A, Darvish H, Validi M, Ebrahimpour S, Nouri HR. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders. Microb Pathog. 2018;117:43–8.PubMedCrossRef Nejati S, Karkhah A, Darvish H, Validi M, Ebrahimpour S, Nouri HR. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders. Microb Pathog. 2018;117:43–8.PubMedCrossRef
10.
Zurück zum Zitat Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vascular Health Risk Manag. 2012;8:455.CrossRef Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vascular Health Risk Manag. 2012;8:455.CrossRef
11.
Zurück zum Zitat Yang X, Gao Y, Zhao X, Tang Y, Su Y. Chronic Helicobacter pylori infection and ischemic stroke subtypes. Neurol Res. 2011;33:467–72.PubMedCrossRef Yang X, Gao Y, Zhao X, Tang Y, Su Y. Chronic Helicobacter pylori infection and ischemic stroke subtypes. Neurol Res. 2011;33:467–72.PubMedCrossRef
12.
Zurück zum Zitat Yu M, Zhang Y, Yang Z, Ding J, Xie C, Lu N. Association between Helicobacter pylori infection and stroke: a meta-analysis of prospective observational studies. J Stroke Cerebrovasc Dis. 2014;23:2233–9.PubMedCrossRef Yu M, Zhang Y, Yang Z, Ding J, Xie C, Lu N. Association between Helicobacter pylori infection and stroke: a meta-analysis of prospective observational studies. J Stroke Cerebrovasc Dis. 2014;23:2233–9.PubMedCrossRef
13.
Zurück zum Zitat Doheim MF, Altaweel AA, Elgendy MG, Elshanbary AA, Dibas M, Ali AAHA, et al. Association between Helicobacter pylori infection and stroke: a meta-analysis of 273,135 patients. J Neurol. 2021;268:3238–48.PubMedCrossRef Doheim MF, Altaweel AA, Elgendy MG, Elshanbary AA, Dibas M, Ali AAHA, et al. Association between Helicobacter pylori infection and stroke: a meta-analysis of 273,135 patients. J Neurol. 2021;268:3238–48.PubMedCrossRef
14.
Zurück zum Zitat Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166:646–55.PubMedCrossRef Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166:646–55.PubMedCrossRef
15.
Zurück zum Zitat Xu Z, Wang L, Lin Y, Wang Z, Zhang Y, Li J, et al. The impacts of peptic ulcer on stroke recurrence. J Stroke Cerebrovasc Dis. 2018;27:2106–11.PubMedCrossRef Xu Z, Wang L, Lin Y, Wang Z, Zhang Y, Li J, et al. The impacts of peptic ulcer on stroke recurrence. J Stroke Cerebrovasc Dis. 2018;27:2106–11.PubMedCrossRef
16.
Zurück zum Zitat Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and stroke risk: a new target for prevention. Stroke. 2021;52:2697–706.PubMedCrossRef Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and stroke risk: a new target for prevention. Stroke. 2021;52:2697–706.PubMedCrossRef
17.
18.
Zurück zum Zitat Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50:524–37.PubMedPubMedCentralCrossRef Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50:524–37.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD, et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet. 2014;94:511–21.PubMedPubMedCentralCrossRef Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD, et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet. 2014;94:511–21.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Ligthart S, Vaez A, Võsa U, Stathopoulou MG, De Vries PS, Prins BP, et al. Genome analyses of> 200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018;103:691–706.PubMedPubMedCentralCrossRef Ligthart S, Vaez A, Võsa U, Stathopoulou MG, De Vries PS, Prins BP, et al. Genome analyses of> 200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018;103:691–706.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman ÅK, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2:1135–48.PubMedPubMedCentralCrossRef Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman ÅK, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2:1135–48.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Guo X, Tang P, Hou C, Liu Y, Li R. Impaired pulmonary function mediates the impact of preterm birth on later-life stroke: a 2-step, multivariable Mendelian randomization study. Epidemiol Health 2023; e2023031. Guo X, Tang P, Hou C, Liu Y, Li R. Impaired pulmonary function mediates the impact of preterm birth on later-life stroke: a 2-step, multivariable Mendelian randomization study. Epidemiol Health 2023; e2023031.
23.
Zurück zum Zitat Kotilea K, Bontems P, Touati E. Epidemiology, diagnosis and risk factors of Helicobacter pylori infection. Adv Exp Med Biol. 2019;1149:17–33.PubMedCrossRef Kotilea K, Bontems P, Touati E. Epidemiology, diagnosis and risk factors of Helicobacter pylori infection. Adv Exp Med Biol. 2019;1149:17–33.PubMedCrossRef
25.
Zurück zum Zitat Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. elife, 2018;7. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. elife, 2018;7.
26.
Zurück zum Zitat Guo X, Chong L, Zhang X, Li R. Immunosuppressants contribute to a reduced risk of Parkinson’s disease in rheumatoid arthritis. Int J Epidemiol. 2022;51:1328–38.PubMedCrossRef Guo X, Chong L, Zhang X, Li R. Immunosuppressants contribute to a reduced risk of Parkinson’s disease in rheumatoid arthritis. Int J Epidemiol. 2022;51:1328–38.PubMedCrossRef
27.
Zurück zum Zitat Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.PubMedPubMedCentralCrossRef Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Kang M-H, Eyun S-i, Park Y-Y. Estrogen-related receptor-gamma influences Helicobacter pylori infection by regulating TFF1 in gastric cancer. Biochem Biophys Res Commun. 2021;563:15–22.PubMedCrossRef Kang M-H, Eyun S-i, Park Y-Y. Estrogen-related receptor-gamma influences Helicobacter pylori infection by regulating TFF1 in gastric cancer. Biochem Biophys Res Commun. 2021;563:15–22.PubMedCrossRef
29.
Zurück zum Zitat Wang B, Yu M, Zhang R, Chen S, Xi Y, Duan G. A meta-analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease. Helicobacter. 2020;25: e12761.PubMedCrossRef Wang B, Yu M, Zhang R, Chen S, Xi Y, Duan G. A meta-analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease. Helicobacter. 2020;25: e12761.PubMedCrossRef
30.
Zurück zum Zitat Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995;63:94–8.PubMedPubMedCentralCrossRef Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995;63:94–8.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol. 2012;2:92.PubMedPubMedCentralCrossRef Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol. 2012;2:92.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Link A, Langner C, Schirrmeister W, Habendorf W, Weigt J, Venerito M, et al. Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA. World J Gastroenterol. 2017;23:4712.PubMedPubMedCentralCrossRef Link A, Langner C, Schirrmeister W, Habendorf W, Weigt J, Venerito M, et al. Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA. World J Gastroenterol. 2017;23:4712.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Pan KF, Formichella L, Zhang L, Zhang Y, Ma JL, Li ZX, et al. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int J Cancer. 2014;134:2118–25.PubMedCrossRef Pan KF, Formichella L, Zhang L, Zhang Y, Ma JL, Li ZX, et al. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int J Cancer. 2014;134:2118–25.PubMedCrossRef
34.
Zurück zum Zitat Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthésy-Theulaz IE. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun. 2006;74:425–34.PubMedPubMedCentralCrossRef Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthésy-Theulaz IE. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun. 2006;74:425–34.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun. 2000;68:3448–54.PubMedPubMedCentralCrossRef Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun. 2000;68:3448–54.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Rustgi SD, Oh A, Hur C. Testing and treating Helicobacter pylori Infection in individuals with family history of gastric cancer is cost-effective. Gastroenterology. 2021;161(2051–2052): e2054. Rustgi SD, Oh A, Hur C. Testing and treating Helicobacter pylori Infection in individuals with family history of gastric cancer is cost-effective. Gastroenterology. 2021;161(2051–2052): e2054.
37.
Zurück zum Zitat Georgakis MK, Malik R, Björkbacka H, Pana TA, Demissie S, Ayers C, et al. Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals. Circ Res. 2019;125:773–82.PubMedPubMedCentralCrossRef Georgakis MK, Malik R, Björkbacka H, Pana TA, Demissie S, Ayers C, et al. Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals. Circ Res. 2019;125:773–82.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Hong S-I, Kim J-S, Bae HJ, Kim WY. C-reactive protein for stroke detection in the emergency department in patients with dizziness without neurological deficits. Front Neurol. 2021;12: 662510.PubMedPubMedCentralCrossRef Hong S-I, Kim J-S, Bae HJ, Kim WY. C-reactive protein for stroke detection in the emergency department in patients with dizziness without neurological deficits. Front Neurol. 2021;12: 662510.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Zhang XG, Xue J, Yang WH, Xu XS, Sun HX, Hu L, et al. Inflammatory markers as independent predictors for stroke outcomes. Brain Behav. 2021;11: e01922.PubMedCrossRef Zhang XG, Xue J, Yang WH, Xu XS, Sun HX, Hu L, et al. Inflammatory markers as independent predictors for stroke outcomes. Brain Behav. 2021;11: e01922.PubMedCrossRef
40.
Zurück zum Zitat Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32:917–24.PubMedCrossRef Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32:917–24.PubMedCrossRef
41.
Zurück zum Zitat Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018;70:61–75.PubMedCrossRef Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018;70:61–75.PubMedCrossRef
42.
Zurück zum Zitat Dix C, Zeller J, Stevens H, Eisenhardt SU, Shing K, Nero TL, et al. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol. 2022;13:1002652.PubMedPubMedCentralCrossRef Dix C, Zeller J, Stevens H, Eisenhardt SU, Shing K, Nero TL, et al. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol. 2022;13:1002652.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513–20.PubMedCrossRef Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513–20.PubMedCrossRef
44.
Zurück zum Zitat Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20:467–84.PubMedCrossRef Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20:467–84.PubMedCrossRef
Metadaten
Titel
Causal associations of circulating Helicobacter pylori antibodies with stroke and the mediating role of inflammation
verfasst von
Xingzhi Guo
Peng Tang
Xin Zhang
Rui Li
Publikationsdatum
15.05.2023
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 6/2023
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-023-01740-0

Weitere Artikel der Ausgabe 6/2023

Inflammation Research 6/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Auf Antibiotika verzichten? Was bei unkomplizierter Zystitis hilft

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.